5Hideshima T,Chauhan D,Shima Y,et al.Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy[J].Blood,2000,96:2943-2950.
6Chen F,Castranova V,Shi X.New insights into the role of nuclear factor-kappaB in cell growth regulation[J].Am J Pathol,2001,159(2):387-397.
7Hicklin D I,Ellis L M.Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis[J].J Clin Oncol,2005,23(5):1011-1027.
8Weidner N.Current pathologic methods for measuring intratumoral microvessle density within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat,1995,36(2):169-173.
9Factor V,Oliver AL,Panta GR,et al.Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice[J].Hepatology,2001,34 (1):32-41.
10Takahashi M,Matsui A,Inao M,et al.ERK/MAPK-dependent PI3K/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells[J].Hepatol Res,2003,26(3):232-236.
4Sen R, Baltimore D. Multiple nuclear factors interact with the immuno-globulin enhancer sequences [ J ]. Cell, 1986,46 ( 5 ) :705 -716.
5Sasaki N, Morisaki T, Hashizume K, et al. Nuclear factor KB p65 (ReLA) transcription factor isconstitutively activated in human gastric carcinoma tissue [ J ]. Clin Cancer Res, 2001,7 ( 12 ) : 4136 -4142.
6Shibata A, Nagaya T, Imai T, et al. Inhibition of NF-KB activity decreases the VEGF mRNA expression in MDA-2 MB231 breast cancer cells [ J ]. Breast Cancer Res Treat,2002,73 ( 3 ) : 237 - 243.
7Gunthert U, Stauder R,Mayer B.et al .Are CD44 variant isofonus involved in human tumour progression [J] .Cancer surv, 1995,(24): 19-42.
8Drillenburg P, Wielenga VJ, Kramer et al .CD44 expression predicts disease outcome in localized large B cell lymphoma ( J ) .Leukemia, 1999( 13 ): 1448-1455.
9Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors [J] .Nat Rev Cancer,2002(2):727-739.
